Advancing Knowledge at the Intersection of Neuropsychopharmacology and Addiction

Stefania, Chiappini

Open Access

Editorial

Advancing Knowledge at the Intersection of Neuropsychopharmacology and Addiction

Giovanni Martinotti^{1, 2}

,

Stefania Chiappini^{3, *}

Author Information

Published: 4 Mar 2025

References

1.

Martinotti, G.; Vita, A.; Fagiolini, A.; et al. Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study). J. Affect. Disord. 2022, 319, 646–654. https://doi.org/10.1016/j.jad.2022.09.043.

2.

Johansen, L.; Liknaitzky, P.; Nedeljkovic, M.; et al. How psychedelic-assisted therapy works for depression: Expert views and practical implications from an exploratory Delphi study. Front. Psychiatry 2023, 14, 1265910. https://doi.org/10.3389/fpsyt.2023.1265910.

3.

Perkins, D.; Sarris, J.; Rossell, S.; et al. Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm. Aust. N. Z. J. Psychiatry 2021, 55, 1127–1133. https://doi.org/10.1177/0004867421998785.

4.

Lima-Ojeda, J.M.; Rupprecht, R.; Baghai, T.C. Neurobiology of depression: A neurodevelopmental approach. World J. Biol. Psychiatry 2018, 19, 349–359. https://doi.org/10.1080/15622975.2017.1289240.

5.

Maj, M.; Stein, D.J.; Parker, G.; et al. The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry 2020, 19, 269–293. https://doi.org/10.1002/wps.20771.

6.

McIntyre, R.S.; Alsuwaidan, M.; Baune, B.T.; et al. Treatment-resistant depression: Definition, prevalence, detection, management, and investigational interventions. World Psychiatry 2023, 22, 394–412. https://doi.org/10.1002/wps.21120.

7.

Volkow, N.D.; Blanco, C. Substance use disorders: A comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention. World Psychiatry 2023, 22, 203–229. https://doi.org/10.1002/wps.21073.

8.

Schifano, F.; Napoletano, F.; Chiappini, S.; et al. New/emerging psychoactive substances and associated psychopathological consequences. Psychol. Med. 2021, 51, 30–42. https://doi.org/10.1017/S0033291719001727. Erratum in: Psychol. Med. 2021, 51, 43. https://doi.org/10.1017/S003329171900254X.

9.

Sampogna, G.; Toni, C.; Catapano, P.; et al. New trends in personalized treatment of depression. Curr. Opin. Psychiatry 2024, 37, 3–8. https://doi.org/10.1097/YCO.0000000000000903.

Share this article:

Download PDF

Issue

Volume 1, Issue 1

How to Cite

Martinotti, G., & Chiappini, S. (2025). Advancing Knowledge at the Intersection of Neuropsychopharmacology and Addiction. Clinical Neuropsychopharmacology and Addiction, 1(1), 1.

RIS

BibTex

Copyright & License

This work is licensed under a This work is licensed under a Creative Commons Attribution 4.0 International License.